-
MASSON(马松)染色结果怎么分析的?
MASSON染色结果的分析主要基于对染色后组织切片中不同组织成分的着色情况进行观察和解读。~~MASSON染色法通过利用不同离子染料的分子大小与组织渗透性的差异
2025-01-18 40 -
MASSON(马松)染色结果怎么看纤维化?
一、MASSON染色结果解读①正常组织染色结果在正常组织中,MASSON染色通常呈现出均匀的蓝色背景,其中肌肉纤维和血管等结构清晰可见。这种染色结果表明组织结构
2025-01-18 81 -
MASSON染色和HE染色区别?
一、MASSON染色:揭示纤维组织的奥秘MASSON染色是一种专门用于显示组织中纤维成分的染色方法。它能够清晰地呈现出胶原纤维、肌肉纤维以及弹性纤维等结构,使得
2025-01-18 158 -
MASSON(马松)染色原理阳性意义
MASSON染色原理及其阳性意义是医学和生物学领域中的关键概念,特别是在对组织结构和成分进行分析时。MASSON染色是一种特殊的组织染色方法,主要依赖于不同离子
2025-01-18 59 -
Detection of Copy Number Variation Using SNP Genotyping
Genetic diversity among human genomes comes in many forms, including single nucl
2025-01-18 14 -
Isolation and Culture of Human Alveolar Epithelial Cells
The human lung comprises more than 40 different cell types. The morphology and f
2025-01-18 12 -
Using Zebrafish (Danio rerio) to Assess Gene Function in Thrombus Formation
Cardiovascular and cerebrovascular disease is the major cause of death in the de
2025-01-18 14 -
细胞生物基本方法:结缔组织类细胞培养
结缔组织类细胞培养1 )成纤维细胞培养用人或动物胚体为好;动物可用小鼠或鸡胚,去头和内脏,剪成小碎块后,用胰蛋白酶消化法培养;如为人胚,可取皮肤培养。幼儿包皮是
2025-01-18 13 -
Treatment of Rat Glioma With Electrochemotherapy
The first attempt to apply electrochemotherapy (ECT) to the brain was reported i
2025-01-18 11 -
紫杉醇(taxol)
紫杉醇是红豆杉属植物中的一种复杂的次生代谢产物, 也是目前所了解的惟一一种可以促进微管聚合和稳定已聚合微管的药物。同位素示踪表明, 紫杉醇只结合到聚合的微管上,
2025-01-18 9 -
原肌球蛋白(tropomyosin, Tm)
原肌球蛋白是细肌丝中与肌动蛋白的结合蛋白,分子量为235kDa, 长为41nm, 由两条平行的多肽链组成α螺旋构型,每条原肌球蛋白首尾相接形成一条连续的链同肌动
2025-01-18 12 -
Proteomics Analysis of Contact-Initiated Eph ReceptorEphrin Signaling
Large-scale biochemical analysis of cell-specific signaling can be interrogated
2025-01-18 9 -
Identifying and Counting Protein Modifications Triggered by Nitrosative Stress
Nitric oxide (NO) is a small, labile molecule that plays a key role as an interc
2025-01-18 7 -
Measurement and Illustration of Immune Interaction After Stem Cell Transplantation
A variety of stem cells, including embryonic, mesenchymal, and hematopoietic ste
2025-01-18 8 -
Antisense Therapeutics: A Promise Waiting to Be Fulfilled
During the past decade, only one antisense-based therapy has received full Food
2025-01-18 8